Volume 9, Number 6, June 2003

Clinical Implications of Varying Degrees of Vancomycin Susceptilibity in Methicillin-Resistant Staphylococcus aureus Bacteremia

Mitchell J. Schwaber,*†‡ Sharon B. Wright,*†Yehuda Carmeli,*†‡ Lata Venkataraman,*† Paola C. DeGirolami,*† Aneta Gramatikova,§ Trish M. Perl,§ George Sakoulas,*† and Howard S. Gold*†
*Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA; †Harvard Medical School, Boston, Massachusetts, USA; ‡Tel Aviv Sourasky Medical Center, Tel Aviv, Israel; and §Johns Hopkins Hospital, Johns Hopkins Medical Institutions, Baltimore, Maryland, USA

Figure 1. Pulsed-field gel electrophoresis of selected isolates, demonstrating predominant and secondary types. Lane 1, Staphylococcus aureus NCTC 8325, used as DNA molecular weight reference marker; lanes 2 and 3, clinical isolates of type A13; lane 4, clinical isolate of type A1; lane 5, clinical isolate of type B2; lane 6, clinical isolate of type H.

EID Home | Top of Page | Ahead-of-Print | Past Issues | Suggested Citation | EID Search | Contact Us | Accessibility | Privacy Policy Notice | CDC Home | CDC Search | Health Topics A-Z

This page last reviewed May 8, 2003

Emerging Infectious Diseases Journal
National Center for Infectious Diseases
Centers for Disease Control and Prevention